Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Cyclocurcumin(P) is a synthetic analog of curcumin, a naturally occurring compound found in the spice turmeric. It exhibits enhanced antioxidant and anti-inflammatory properties compared to curcumin, positioning it as a promising candidate for the development of new therapeutic agents targeting conditions such as cancer, arthritis, inflammatory diseases, and neurodegenerative disorders.

153127-42-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 153127-42-5 Structure
  • Basic information

    1. Product Name: CYCLOCURCUMIN(P)
    2. Synonyms: CYCLOCURCUMIN(P)
    3. CAS NO:153127-42-5
    4. Molecular Formula: C21H20O6
    5. Molecular Weight: 368.383
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 153127-42-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 571.9±50.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: Yellow Powder
    5. Density: 1.352±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 9.66±0.35(Predicted)
    10. CAS DataBase Reference: CYCLOCURCUMIN(P)(CAS DataBase Reference)
    11. NIST Chemistry Reference: CYCLOCURCUMIN(P)(153127-42-5)
    12. EPA Substance Registry System: CYCLOCURCUMIN(P)(153127-42-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 153127-42-5(Hazardous Substances Data)

153127-42-5 Usage

Uses

Used in Pharmaceutical Industry:
Cyclocurcumin(P) is used as a therapeutic agent for its potential anti-inflammatory and anti-cancer properties. Its stronger antioxidant and anti-inflammatory activity compared to curcumin makes it a valuable compound for the treatment of conditions like cancer, arthritis, and inflammatory diseases.
Used in Neurodegenerative Disease Treatment:
Cyclocurcumin(P) is used as a neuroprotective agent due to its potential to treat neurodegenerative diseases. Research suggests that its potent biological activities could be beneficial in managing such conditions, further emphasizing its value in pharmaceutical development.
Used in Antioxidant Formulations:
Cyclocurcumin(P) is used as an antioxidant in various formulations to leverage its enhanced antioxidant capacity. This application can be beneficial across different industries, including pharmaceuticals, cosmetics, and dietary supplements, to provide protection against oxidative stress and related health issues.

Check Digit Verification of cas no

The CAS Registry Mumber 153127-42-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,1,2 and 7 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 153127-42:
(8*1)+(7*5)+(6*3)+(5*1)+(4*2)+(3*7)+(2*4)+(1*2)=105
105 % 10 = 5
So 153127-42-5 is a valid CAS Registry Number.

153127-42-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name CYCLOCURCUMIN(P)

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:153127-42-5 SDS

153127-42-5Downstream Products

153127-42-5Relevant articles and documents

Nematocidal activity of turmeric: Synergistic action of curuminoids

Kiuchi,Goto,Sugimoto,Akao,Kondo,Tsuda

, p. 1640 - 1643 (1993)

A new curcuminoid, cyclocurcumin (IV), was isolated from the nematocidally active fraction of turmeric, the rhizome of Curcuma longa, together with three known curcuminoids, curcumin (I), demethoxycurcumin (II) and bisdemethoxycurcumin (III). The structur

An insight into cyclocurcumin cis–trans isomerization: Kinetics in solution and in the presence of silver nanoparticles

Angelini, Guido,Gansmüller, Axel,Pécourneau, Jérémy,Gasbarri, Carla

, (2021)

Cyclocurcumin (CyCUR) is a non-diarylheptanoid curcuminoid characterized by an α,β-unsaturated dihydropyranone moiety generally existing as trans isomer in the ground state but able to convert into the cis form by photoisomerization. Herein the kinetics of thermal cis–trans isomerization of cyclocurcumin was spectroscopically determined in ethanol, pure water and silver nanoparticles (AgNPs) aqueous solution. Energetic parameters were calculated by Arrhenius and Eyring plots in the temperature range 294–314 K. The presence of AgNPs increases the rate of the reaction, according to the polarizability of the environment. The solvatochromism of cyclocurcumin was also studied by using the Catalán empirical solvent parameters scale in a series of organic solvents. The bathochromic shift of CyCUR suggests that polarizability of the medium plays the major role in the investigated conditions.

The effectiveness of natural diarylheptanoids against Trypanosoma cruzi: Cytotoxicity, ultrastructural alterations and molecular modeling studies

Sueth-Santiago, Vitor,De Moraes, Jullianede B. B.,Alves, Eliomara Sousa Sobral,Vannier-Santos, Marcos Andre,Freire-De-lima, Celio G.,Castro, Rosane N.,Mendes-Silva, Gustavo Peron,De Nigris Del Cistia, Catarina,Magalh?es, Luma Godoy,Andricopulo, Adriano Defini,Santánna, Carlos Mauricio R.,Decote-Ricardo, Debora,Edilsonfreiredelima, Marco

, (2016)

Curcumin (CUR) is the major constituent of the rhizomes of Curcuma longa and has been widely investigated for its chemotherapeutic properties. The well-known activity of CUR against Leishmania sp., Trypanosoma brucei and Plasmodium falciparum led us to investigate its activity against Trypanosoma cruzi. In this work, we tested the cytotoxic effects of CUR and other natural curcuminoids on different forms of T. cruzi, as well as the ultrastructural changes induced in epimastigote form of the parasite. CUR was verified as the curcuminoid with more significant trypanocidal properties (IC50 10.13 μM on epimastigotes). Demethoxycurcumin (DMC) was equipotent to CUR (IC50 11.07 μM), but bisdemethoxycurcumin (BDMC) was less active (IC50 45.33 μM) and cyclocurcumin (CC) was inactive. In the experiment with infected murine peritoneal macrophages all diarylheptanoids were more active than the control in the inhibition of the trypomastigotes release. The electron microscopy images showed ultrastructural changes associated with the cytoskeleton of the parasite, indicating tubulin as possible target of CUR in T. cruzi. The results obtained by flow cytometry analysis of DNA content of the parasites treated with natural curcuminoids suggested a mechanism of action on microtubules related to the paclitaxel's mode of action. To better understand the mechanism of action highlighted by electron microscopy and flow cytometry experiments we performed the molecular docking of natural curcuminoids on tubulin of T. cruzi in a homology model and the results obtained showed that the observed interactions are in accordance with the IC50 values found, since there CUR and DMC perform similar interactions at the binding site on tubulin while BDMC do not realize a hydrogen bond with Lys163 residue due to the absence of methoxyl groups. These results indicate that trypanocidal properties of CUR may be related to the cytoskeletal alterations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 153127-42-5